Clinical Trial Update: Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant oophorectomy plus tamoxifen in premenopausal women with hormone receptor-positive breast cancer has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: International Breast Cancer Research Foundation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-04-29